ZAFEKTIN

Details for Australian Trade Mark No. 1035801 (hide)

Owner Biogen Idec MA Inc.

Convention US 25 JUNE 2004 76/599253

Service Freehills

Various Convention priority claimed: 25 June 2004, United States of America, No. 76/599253 in respect of PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF DERMATOLOGICAL DISORDERS, ANTOIMMUNE DISORDERS, NEUROLOGICAL DISORDERS, PSORIASIS, M U L T I P L E S C

Filing Date 22 December 2004

Classes

Class 5 Pharmaceutical products and pharmaceutical preparations; pharmaceutical preparations for use in the treatment of dermatological disorders, antoimmune disorders, neurological disorders, psoriasis, multiple sclerosis, Crohn's disease, transplant rejection (host-vs-graft or graft-vs-host reaction), and mitochondrial

Event Publications

13 January 2005 Application filed

13 January 2005 Application Accepted

28 April 2005 Opposition Filed

  MERCK KGAA has filed an opposition against Biogen Idec MA Inc.

2 February 2006 Application/IR Amended and Changed

  Amended Class 5 "Prescription pharmaceuticals for the treatment of neurological, oncological and immunological disorders".

8 June 2006 Opposition Discontinued

  The opposition of MERCK KGAA against Biogen Idec MA Inc. has been discontinued.

8 June 2006 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1035802-ALDYLEN

1035800-PANACLAR